Status:
SUSPENDED
Group CBT for Intolerance of Uncertainty
Lead Sponsor:
University of Manitoba
Conditions:
Generalized Anxiety Disorder
Intolerance of Uncertainty
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
Generalized anxiety disorder (GAD) is a debilitating condition involving excessive and uncontrollable worry and anxiety. Difficulty tolerating the uncertainties of life, known as intolerance of uncert...
Eligibility Criteria
Inclusion
- Primary diagnosis of generalized anxiety disorder (GAD)
- High Intolerance of uncertainty (IU)
Exclusion
- Comorbid psychosis, organic brain disorder, bipolar disorder, or current substance use disorder
- Receiving concurrent psychological treatments or other counselling
- Psychotropic medications must remain stable during the study period and for 3 months prior to intervention
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04512378
Start Date
February 1 2021
End Date
December 31 2025
Last Update
August 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Boniface General Hospital
Winnipeg, Manitoba, Canada, R2H 2A6
2
Deer Lodge Centre
Winnipeg, Manitoba, Canada, R3J 0L3